Robust Anti‐Tumor T Cell Response with Efficient Intratumoral Infiltration by Nanodisc Cancer Immunotherapy

Author:

Kuai Rui12,Singh Priti B.3,Sun Xiaoqi12,Xu Cheng12,Hassani Najafabadi Alireza12,Scheetz Lindsay12,Yuan Wenmin12,Xu Yao12,Hong Hao4,Keskin Derin B.567,Wu Catherine J.5678,Jain Renu3,Schwendeman Anna12,Moon James J.129ORCID

Affiliation:

1. Department of Pharmaceutical Sciences University of Michigan Ann Arbor MI 48109 USA

2. Biointerfaces Institute University of Michigan Ann Arbor MI 48109 USA

3. Bristol Myers Squibb Redwood City CA 94063 USA

4. State Key Laboratory of Pharmaceutical Biotechnology Medical School of Nanjing University Nanjing University Nanjing 210093 China

5. Broad Institute of MIT and Harvard Cambridge MA 02142 USA

6. Department of Medical Oncology Dana‐Farber Cancer Institute Boston MA 02215 USA

7. The Translational Immunogenomics Lab (TIGL) Dana‐Farber Cancer Institute Boston MA 02215 USA

8. Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA

9. Department of Biomedical Engineering University of Michigan Ann Arbor MI 48109 USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry (medical),Genetics (clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3